These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35118828)

  • 1. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
    Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of aMMP-8 and azurocidin in peri-implant sulcular fluid as biomarkers of peri-implant health or disease.
    Xanthopoulou V; Räisänen IT; Sorsa T; Tortopidis D; Sakellari D
    Clin Exp Dent Res; 2024 Jun; 10(3):e883. PubMed ID: 38853451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases.
    Alassiri S; Parnanen P; Rathnayake N; Johannsen G; Heikkinen AM; Lazzara R; van der Schoor P; van der Schoor JG; Tervahartiala T; Gieselmann D; Sorsa T
    Dis Markers; 2018; 2018():1306396. PubMed ID: 30154936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active MMP-8 as a Biomarker of Peri-implant Health or Disease.
    Xanthopoulou V; Räisänen I; Sorsa T; Sakellari D
    Eur J Dent; 2023 Jul; 17(3):924-928. PubMed ID: 36063841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of matrix metalloproteinase-8 and -9 levels in the peri-implant sulcular fluid among waterpipe (narghile) smokers and never-smokers with peri-implantitis.
    Al-Sowygh ZH; Aldamkh MK; Binmahfooz AM; Al-Aali KA; Akram Z; Qutub OA; Javed F; Abduljabbar T
    Inhal Toxicol; 2018 Feb; 30(2):72-77. PubMed ID: 29564945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. aMMP-8 point-of-care - diagnostic methods and treatment modalities in periodontitis and peri-implantitis.
    Lähteenmäki H; Pätilä T; Pärnänen CP; Räisänen I; Tervahartiala T; Gupta S; Sorsa T
    Expert Opin Ther Targets; 2023; 27(7):627-637. PubMed ID: 37522314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laminin-5 gamma2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid.
    Kivelä-Rajamäki MJ; Teronen OP; Maisi P; Husa V; Tervahartiala TI; Pirilä EM; Salo TA; Mellanen L; Sorsa TA
    Clin Oral Implants Res; 2003 Apr; 14(2):158-65. PubMed ID: 12656874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
    Sorsa T; Nwhator SO; Sakellari D; Grigoriadis A; Umeizudike KA; Brandt E; Keskin M; Tervahartiala T; Pärnänen P; Gupta S; Mohindra R; Bostanci N; Buduneli N; Räisänen IT
    Front Oral Health; 2022; 3():897115. PubMed ID: 35757444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological and aMMP-8 findings depending on peri-implant disease in patients undergoing supportive implant therapy.
    Ziebolz D; Schmalz G; Gollasch D; Eickholz P; Rinke S
    Diagn Microbiol Infect Dis; 2017 May; 88(1):47-52. PubMed ID: 28274501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-derived biomarkers at teeth and implants in partially edentulous patients. A 10-year retrospective study.
    Ramseier CA; Eick S; Brönnimann C; Buser D; Brägger U; Salvi GE
    Clin Oral Implants Res; 2016 Feb; 27(2):211-7. PubMed ID: 25682848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-implant phenotype, calprotectin and MMP-8 levels in cases diagnosed with peri-implant disease.
    Önder YB; Alpaslan NZ
    Clin Oral Investig; 2024 Jun; 28(7):404. PubMed ID: 38940878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
    Lähteenmäki H; Umeizudike KA; Heikkinen AM; Räisänen IT; Rathnayake N; Johannsen G; Tervahartiala T; Nwhator SO; Sorsa T
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study.
    Xu L; Yu Z; Lee HM; Wolff MS; Golub LM; Sorsa T; Kuula H
    Acta Odontol Scand; 2008 Aug; 66(4):219-24. PubMed ID: 18615324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of active matrix metalloproteinase-8 (aMMP-8) chair-side test as a diagnostic biomarker in the staging of periodontal diseases.
    Öztürk VÖ; Emingil G; Umeizudike K; Tervahartiala T; Gieselmann DR; Maier K; Köse T; Sorsa T; Alassiri S
    Arch Oral Biol; 2021 Apr; 124():104955. PubMed ID: 33556789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid.
    Kivelä-Rajamäki M; Maisi P; Srinivas R; Tervahartiala T; Teronen O; Husa V; Salo T; Sorsa T
    J Periodontal Res; 2003 Dec; 38(6):583-90. PubMed ID: 14632921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein biomarkers and microbial profiles in peri-implantitis.
    Wang HL; Garaicoa-Pazmino C; Collins A; Ong HS; Chudri R; Giannobile WV
    Clin Oral Implants Res; 2016 Sep; 27(9):1129-36. PubMed ID: 26424287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulcus fluid bone marker levels and the outcome of surgical treatment of peri-implantitis.
    Wohlfahrt JC; Aass AM; Granfeldt F; Lyngstadaas SP; Reseland JE
    J Clin Periodontol; 2014 Apr; 41(4):424-31. PubMed ID: 24417563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Fluid Biomarkers for Peri-Implantitis: A Scoping Review.
    Lumbikananda S; Srithanyarat SS; Mattheos N; Osathanon T
    Int Dent J; 2024 Jun; 74(3):387-402. PubMed ID: 38065782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.